An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress.
3D model
bioreactor
glaucoma
trabecular meshwork
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
09 Nov 2021
09 Nov 2021
Historique:
received:
24
09
2021
revised:
26
10
2021
accepted:
08
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
16
12
2021
Statut:
epublish
Résumé
Primary Open-Angle Glaucoma (POAG) is a neurodegenerative disease, and its clinical outcomes lead to visual field constriction and blindness. POAG's etiology is very complex and its pathogenesis is mainly explained through both mechanical and vascular theories. The trabecular meshwork (TM), the most sensitive tissue of the eye anterior segment to oxidative stress (OS), is the main tissue involved in early-stage POAG, characterized by an increase in pressure. Preclinical assessments of neuroprotective drugs on animal models have not always shown correspondence with human clinical studies. In addition, intra-ocular pressure management after a glaucoma diagnosis does not always prevent blindness. Recently, we have been developing an innovative in vitro 3Dadvanced human trabecular cell model on a millifluidicplatform as a tool to improve glaucoma studies. Herein, we analyze the effects of prolonged increased pressure alone and, in association with OS, on such in vitro platform. Moreover, we verify whethersuch damaged TM triggers apoptosis on neuron-like cells. The preliminary results show that TM cells are less sensitive to pressure elevation than OS, and OS-damaging effects were worsened by the pressure increase. The stressed TM releases harmful signals, which increase apoptosis stimuli on neuron-like cells, suggesting its pivotal role in the glaucoma cascade.
Identifiants
pubmed: 34830007
pii: ijms222212129
doi: 10.3390/ijms222212129
pmc: PMC8622817
pii:
doi:
Substances chimiques
Neuroprotective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Optom. 2017 Apr - Jun;10(2):71-78
pubmed: 27025415
Prog Retin Eye Res. 2021 Jan;80:100875
pubmed: 32659431
Exp Eye Res. 2021 Apr;205:108494
pubmed: 33596442
Ageing Res Rev. 2016 Aug;29:26-41
pubmed: 27242026
Lancet Psychiatry. 2015 Jan;2(1):105-10
pubmed: 26359616
Exp Eye Res. 2018 Jun;171:164-173
pubmed: 29526795
Methods Mol Biol. 2011;695:1-15
pubmed: 21042962
J Clin Med. 2020 Nov 06;9(11):
pubmed: 33172106
Arch Biochem Biophys. 2021 Apr 15;701:108815
pubmed: 33609537
Ophthalmologica. 1998;212(4):268-74
pubmed: 9672217
J Cell Mol Med. 2013 Dec;17(12):1619-31
pubmed: 24118792
Transl Neurosci. 2018 Nov 12;9:132-141
pubmed: 30473883
Surv Ophthalmol. 2021 Sep-Oct;66(5):693-713
pubmed: 33582161
J Am Assoc Lab Anim Sci. 2015 Mar;54(2):120-32
pubmed: 25836957
Exp Eye Res. 2011 Aug;93(2):204-12
pubmed: 20691180
Toxicol In Vitro. 2017 Jun;41:21-29
pubmed: 28214551
Diagnostics (Basel). 2020 Dec 24;11(1):
pubmed: 33374330
J Neurotrauma. 2002 Mar;19(3):369-78
pubmed: 11939504
Med Res Rev. 2021 Jan;41(1):29-71
pubmed: 32808366
Clin Ophthalmol. 2008 Dec;2(4):879-89
pubmed: 19668442
Biotechnol Bioeng. 2017 Apr;114(4):915-923
pubmed: 27775151
Ophthalmology. 2018 Dec;125(12):1874-1885
pubmed: 30082073
ALTEX. 2020 Jan 27;37(2):265-274
pubmed: 32052854
Transl Vis Sci Technol. 2015 Mar 9;4(2):1
pubmed: 25767744
J Immunol. 2016 Dec 15;197(12):4626-4638
pubmed: 27849168
J Clin Med. 2020 Sep 30;9(10):
pubmed: 33007927
World J Stem Cells. 2019 Dec 26;11(12):1065-1083
pubmed: 31875869
Biotechnol Bioeng. 2016 Jun;113(6):1357-68
pubmed: 26615056
PLoS One. 2019 Sep 6;14(9):e0221942
pubmed: 31490976
Exp Eye Res. 2021 Mar;204:108449
pubmed: 33465395
J Ophthalmol. 2016;2016:6509809
pubmed: 27895937
Am J Ophthalmol. 2011 Nov;152(5):715-6
pubmed: 22017839
Prog Retin Eye Res. 2021 Sep;84:100953
pubmed: 33640464
J Glaucoma. 2009 Feb;18(2):93-100
pubmed: 19225343
Cell Signal. 2010 May;22(5):828-35
pubmed: 20074641
Curr Eye Res. 2020 Mar;45(3):327-338
pubmed: 31475591
Free Radic Biol Med. 2010 Apr 15;48(8):1064-70
pubmed: 20100568
Invest Ophthalmol Vis Sci. 2009 May;50(5):2194-200
pubmed: 19060281